Fortress Biotech, Inc.
For the period ended Jan 13, 2026. Filed Jan 13, 2026.
View on SEC.govAbout this filing
A notice of a major event between regular reports, such as results, a deal or a change of executives. It is often the first formal record of the news.
Jan 13, 2026 · Filed Jan 13, 2026
Use the contents to explore the available documents and sections.
FBIO$1.85+0.5%Stored close · as of Nov 6, 2026
Contents
EX-99.1 · Liver Dysfunction
Liver Dysfunction
Copper accumulation can result in liver dysfunction. The healthcare team will monitor your child's liver function through periodic laboratory tests before and during ZYCUBO administration. The dose of ZYCUBO may be adjusted as appropriate based on the results of the laboratory tests.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.